Seagen Inc
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
156.21
2.64
(1.719%)
Volume:
1,375,861
52 week range:
133.2 - 213.94
Market Cap:
28.42B
Company Description:
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union.